LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3kinase/Akt/fatty acid synthase signaling pathway in vitro

Publisher： Spandidos Publications

E-ISSN： 1791-3004|11|2|1352-1357

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.11, Iss.2, 2015-01, pp. : 1352-1357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 2967-2972

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro

By              

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 608-612

Spandidos Publications

Access to resources Recommend Favorite

PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus

By              

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1581-1588

Spandidos Publications

Access to resources Recommend Favorite

Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway

By          

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1401-1406

Spandidos Publications

Access to resources Recommend Favorite

Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro

By                    

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 328-334

Spandidos Publications

Access to resources Recommend Favorite